Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 13Motor Activity 5Colorectal Neoplasms 5Smoking Cessation 4Neoplasms 4Lung Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Smoking 2Prostatic Neoplasms 2Papillomavirus Infections 2Colonic Neoplasms 2Behavior 2Skin Cancer Prevention 1Polycystic Ovary Syndrome 1Patient Compliance 1Pancreatic Neoplasms 1Overweight 1Ovarian Neoplasms 1Other Cancer 1Obesity 1Melanoma 1Medication Adherence 1Lymphedema 1Gastrointestinal Neoplasms 1Colorectal Cancer Screening 1Chronic Pain 1Body Weight Changes 1Body Weight 1Anxiety Disorders 1

Interventions

Standard of Care 3Self-Management 1Pharmacists 1Pharmaceutical Services 1Palliative Care 1Motivational Interviewing 1Hypnosis 1Historically Controlled Study 1General Practitioners 1Drug Delivery Systems 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Medication Adherence × Motivational Interviewing × Clear all
NCT02883361 2024-12-05

MI for AIs

University of Calgary

Phase 2/3 Withdrawn
Breast

Breast Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡